Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dentsply Sirona (XRAY) Common Equity (2016 - 2025)

Dentsply Sirona (XRAY) has disclosed Common Equity for 17 consecutive years, with $1.3 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Common Equity fell 31.0% year-over-year to $1.3 billion, compared with a TTM value of $1.3 billion through Dec 2025, down 31.0%, and an annual FY2025 reading of $1.3 billion, down 31.0% over the prior year.
  • Common Equity was $1.3 billion for Q4 2025 at Dentsply Sirona, down from $1.5 billion in the prior quarter.
  • Across five years, Common Equity topped out at $5.1 billion in Q3 2021 and bottomed at $1.3 billion in Q4 2025.
  • Average Common Equity over 5 years is $3.4 billion, with a median of $3.5 billion recorded in 2022.
  • The sharpest move saw Common Equity grew 9.24% in 2021, then crashed 41.04% in 2024.
  • Year by year, Common Equity stood at $5.0 billion in 2021, then decreased by 23.71% to $3.8 billion in 2022, then dropped by 13.59% to $3.3 billion in 2023, then crashed by 41.04% to $1.9 billion in 2024, then crashed by 31.0% to $1.3 billion in 2025.
  • Business Quant data shows Common Equity for XRAY at $1.3 billion in Q4 2025, $1.5 billion in Q3 2025, and $2.0 billion in Q2 2025.